標(biāo)題: Titlebook: Gene Therapy and Gene Delivery Systems; David V. Schaffer,Weichang Zhou Book 2005 Springer-Verlag Berlin Heidelberg 2005 Herman.biotechnol [打印本頁(yè)] 作者: 司法權(quán) 時(shí)間: 2025-3-21 17:26
書目名稱Gene Therapy and Gene Delivery Systems影響因子(影響力)
書目名稱Gene Therapy and Gene Delivery Systems影響因子(影響力)學(xué)科排名
書目名稱Gene Therapy and Gene Delivery Systems網(wǎng)絡(luò)公開(kāi)度
書目名稱Gene Therapy and Gene Delivery Systems網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱Gene Therapy and Gene Delivery Systems被引頻次
書目名稱Gene Therapy and Gene Delivery Systems被引頻次學(xué)科排名
書目名稱Gene Therapy and Gene Delivery Systems年度引用
書目名稱Gene Therapy and Gene Delivery Systems年度引用學(xué)科排名
書目名稱Gene Therapy and Gene Delivery Systems讀者反饋
書目名稱Gene Therapy and Gene Delivery Systems讀者反饋學(xué)科排名
作者: Cervical-Spine 時(shí)間: 2025-3-21 22:50
Production and Formulation of Adenovirus Vectors,ovirus becoming a “well-characterized biological”;and liquid formulations have been developed which maintain virus infectivity at 2–8°C forover 18 months. These and other advances in the production of adenovirus vectors are discussed indetail in this review. In addition, the needs for the next decade are highlighted.作者: Conduit 時(shí)間: 2025-3-22 03:30
Guanidinoacetate N-methyltransferase,llenges in the field of molecular conjugates is how to integrate the components into a?workablesystem that exploits the combined attributes of the components without suffering losses due to theassembly of the system. We discuss some of the difficulties involved in the assembly of a?functioningdelivery system for in vivo use.作者: 核心 時(shí)間: 2025-3-22 05:55 作者: 天氣 時(shí)間: 2025-3-22 09:58 作者: SNEER 時(shí)間: 2025-3-22 15:01 作者: SNEER 時(shí)間: 2025-3-22 20:24 作者: 元音 時(shí)間: 2025-3-22 22:44 作者: Ordeal 時(shí)間: 2025-3-23 03:19 作者: 易達(dá)到 時(shí)間: 2025-3-23 09:14
Cellulose synthase (UDP-forming), uptake of the plasmid by cells and expression ofthe encoded proteins. After this discovery, a?period of technological improvements in plasmiddelivery and expression and in pharmaceutical and manufacturing development was quickly followed bya?plethora of human clinical trials testing the ability of 作者: FORGO 時(shí)間: 2025-3-23 12:14
https://doi.org/10.1007/978-3-540-49755-4n the nonviral delivery of antigen-encoded plasmid DNA for the purpose of treating cancer through the human immune system, as this disease has drawn the most attention in this field to date. Brief overviews of dendritic cell immunobiology and the mechanism of immune activation through genetic vaccin作者: dominant 時(shí)間: 2025-3-23 13:51 作者: 西瓜 時(shí)間: 2025-3-23 18:16 作者: Conquest 時(shí)間: 2025-3-24 00:55
Dietmar Schomburg,Ida Schomburgrated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed. 作者: paltry 時(shí)間: 2025-3-24 05:41 作者: 合唱團(tuán) 時(shí)間: 2025-3-24 10:10 作者: MARS 時(shí)間: 2025-3-24 10:46
Dietmar Schomburg,Ida Schomburgrated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed. 作者: 脫毛 時(shí)間: 2025-3-24 17:10
Lentiviral Vectors,rated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed. 作者: stress-response 時(shí)間: 2025-3-24 22:31
David V. Schaffer,Weichang ZhouCovers trends in modern biotechnology.All aspects of this interdisciplinary technology, where knowledge, methods and expertise are required from chemistry, biochemistry, microbiology, genetics, chemic作者: 乞丐 時(shí)間: 2025-3-25 01:29 作者: 與野獸博斗者 時(shí)間: 2025-3-25 07:09 作者: extract 時(shí)間: 2025-3-25 10:33 作者: STYX 時(shí)間: 2025-3-25 15:31 作者: FLUSH 時(shí)間: 2025-3-25 19:09 作者: 側(cè)面左右 時(shí)間: 2025-3-25 23:40
Nonviral Delivery of Cancer Genetic Vaccines,n the nonviral delivery of antigen-encoded plasmid DNA for the purpose of treating cancer through the human immune system, as this disease has drawn the most attention in this field to date. Brief overviews of dendritic cell immunobiology and the mechanism of immune activation through genetic vaccin作者: 我沒(méi)有命令 時(shí)間: 2025-3-26 00:19 作者: paragon 時(shí)間: 2025-3-26 07:22
Advanced Targeting Strategies for Murine Retroviral and Adeno-associated Viral Vectors,lusively, or stealthing the vector against nonspecific interactions with host cells and proteins. These approaches offer the potential advantages of enhanced therapeutic effects, reduced side effects, lowered dosages, and enhanced therapeutic economics. This review will discuss a?variety of targetin作者: Gum-Disease 時(shí)間: 2025-3-26 08:56
Lentiviral Vectors,rated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed. 作者: Mitigate 時(shí)間: 2025-3-26 14:15
Production and Formulation of Adenovirus Vectors,replacement therapy for protein deficiencies tocancer therapeutics to prophylactic vaccines. Consequently, considerable product, process, analytical, and formulation development has been undertaken to support these programs. For example, “gutless”vectors have been developed in order to improve gene 作者: Handedness 時(shí)間: 2025-3-26 19:21
,Adeno-associated Virus as a?Gene Therapy Vector: Vector Development, Production and Clinical Appliclia B, cystic fibrosis, alpha-1-antitrypsin deficiency, and Canavan disease have begun, and reports from these phase I trials support the safety seen in preclinical trials. Eventually, tissue-specific vectors that can potentially evade the immune system will be required to optimize success in gene t作者: 摻和 時(shí)間: 2025-3-26 23:51
Advanced Targeting Strategies for Murine Retroviral and Adeno-associated Viral Vectors,, high-throughput library and directed evolution approaches can yield significant improvements in vector function. These two complementary strategies offer the potential to gain enhanced molecular control over vector properties and overcome challenges in generating high titer, stealthy, retargeted v作者: majestic 時(shí)間: 2025-3-27 01:34 作者: 做事過(guò)頭 時(shí)間: 2025-3-27 05:58
2-Dehydro-3-deoxygluconokinase,, high-throughput library and directed evolution approaches can yield significant improvements in vector function. These two complementary strategies offer the potential to gain enhanced molecular control over vector properties and overcome challenges in generating high titer, stealthy, retargeted v作者: PHON 時(shí)間: 2025-3-27 13:23 作者: Nerve-Block 時(shí)間: 2025-3-27 15:45
,Versuche einer inhaltbezogenen deutschen Syntax 1958–1963,chtigt und verbindet“ (S. V–VI). Da es hier aber gerade auch darauf ankommt, die . syntaktischer Ergebnisse zu durchschauen, werde ich neben dem ?Abri?“ den Aufsatz ?Prinzipielles zur Syntaxforschung? von 1955 heranziehen (vgl. oben S. 55), wo Erben seine Ziele und Verfahren genauer erl?utert.作者: ADJ 時(shí)間: 2025-3-27 19:33
Recent Studies on Earthquake Performance Assessment of Hagia Sophia in Istanbul of strengthening alternatives and monitoring of its static deformations via laser technology. This contribution presents an overall picture of the research efforts carried out so far on earthquake response analysis of Hagia Sophia, emphasizing the studies over the last 5?years.作者: 向外供接觸 時(shí)間: 2025-3-28 01:14
